BIB
ProShares Ultra Nasdaq Biotechnology
Set alert
120.53 USD +0.37 +0.31%
120.00 Day range 125.27
68.29 52-week range 126.22
- YTD
- +51.08%
- 1 year
- +72.58%
- Open
- 122.20
- Prev close
- 120.16
- Mkt cap
- 103.65M
- Vol
- 27.15K
- Avg vol
- 9.54K
- EPS
- 3.53
- P/E
- 34.13
- Div yield
- 0.00%
More statistics
- Low
- 120.00
- High
- 125.27
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 59.52
- 200-d avg
- 59.79
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 59.52
- 200-day average
- 59.79
About ProShares Ultra Nasdaq Biotechnology
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
News
- Capital Investment Advisors LLC Acquires New Holdings in ProShares Ultra Nasdaq Biotechnology $BIB
- Man in Germany Cured of HIV After Undergoing Stem Cell Transplant, According to Report in Nature Medicine
- Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
- Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy
- If Stocks Keep Soaring, Get to Know These Leveraged ETFs
- ProShares to Split 2, Reverse Split 9 ETFs
- Low Volume, High Returns for These ETFs (BIB, FHC, DRW)
Your note
Sign in to keep a note on BIB — it syncs with the Stock Master app.